CVS Health Corporation has seen varied activity in their stocks as revealed by several asset management firms. Some firms like
Brandywine Global Investment Management LLC,
Empowered Funds LLC, and
SG Amercias Securities LLC reduced their holdings in the CVS stock. Meanwhile, several firms such as
Vanguard Group Inc,
Primecap Management Co. CA, and
Universal Beteiligungs und Servicegesellschaft mbH have increased their stake.
CEO David Joyner has consolidated power within the company with a new chairman role. The corporation has released their Q3 results, which were strong, boosting the outlook for the foreseeable future. Further, CVS has higher guidance as their insurance business improves, and they anticipate double-digit earnings growth by 2026. Additionally,
J.David Joyner's appointment as Chair, alongside several new investments, are set to blue-print an innovative trajectory for CVS. Critically though, a false claim settlement agreement has been reached for $18.2M against
CVS Pharmacy Inc. Lastly, new AI-based initiatives like the
Aetna's Generative AI Assistant are aimed to simplify health care.
Cvs Health Corporation CVS News Analytics from Fri, 04 Apr 2025 14:14:51 GMT to Sat, 22 Nov 2025 10:05:32 GMT -
Rating 7
- Innovation 5
- Information 6
- Rumor 1
